Ritter Pharmaceuticals Inc (NASDAQ:RTTR)’s share price was up 5.2% during mid-day trading on Wednesday . The company traded as high as $0.20 and last traded at $0.19, approximately 937,890 shares traded hands during trading. An increase of 64% from the average daily volume of 570,180 shares. The stock had previously closed at $0.18.
Separately, ValuEngine raised Ritter Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, September 30th.
The business has a 50-day moving average price of $0.24 and a 200-day moving average price of $0.68. The company has a market capitalization of $1.94 million, a price-to-earnings ratio of -0.05 and a beta of 1.02.
Ritter Pharmaceuticals (NASDAQ:RTTR) last announced its earnings results on Wednesday, November 13th. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.23).
About Ritter Pharmaceuticals (NASDAQ:RTTR)
Ritter Pharmaceuticals, Inc develops and sells novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which has completed Phase 2b clinical trial for the reduction of symptoms associated with lactose intolerance.
Recommended Story: Stock Split
Receive News & Ratings for Ritter Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ritter Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.